Novel Chromogenic Medium CHROMagar Candida Plus for Detection of and Other Species from Surveillance and Environmental Samples: A Multicenter Study.

Epidemiological trends show a dramatic increase in the prevalence of fungal infections, and in the isolation of multidrug-resistant species, such as CHROMagar Candida (CC; CHROMagar, Paris, France) and other chromogenic media, which are widely used in the clinical laboratory because they allow a rapid identification of most species. Recently, CHROMagar Candida Plus (CC-Plus; CHROMagar, Paris, France) was developed to detect and differentiate in addition to other major clinical species, such as , . , , or display a differential light blue color with a blue halo.